0
18. 4. 2025.
Neratinib and metformin: A novel therapeutic approach against HER2-Positive Breast Cancer.
Neratinib and metformin: A novel therapeutic approach against HER2-Positive Breast Cancer.
Ova stranica koristi kolačiće da bi vam pružila najbolje iskustvo
Saznaj više